跳至主要内容
临床试验/NCT01232842
NCT01232842已完成不适用

Assessment of Stem Cell Heterogeneity in AML in Co-Culture Systems Using X Chromosome Inactivation Patterns

Children's Oncology Group0 个研究点目标入组 20 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
主要终点
Frequency of AML that originate in CD33+ or in which uncontrolled growth is restricted to CD33+ precursors

研究概览

简要总结

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in tissue samples from patients with acute myeloid leukemia.

详细描述

OBJECTIVES:

  • Determine the frequency of acute myeloid leukemia (AML) that originates in CD33+ precursors or in which uncontrolled growth is restricted to CD33+ precursors.

OUTLINE: Cryopreserved acute myeloid leukemia cell samples are separated from endothelial cell by fluorescent-activated cell sorting (FACS) and analyzed for X-chromosome inactivation patterns by cytogenetic/molecular analysis and/or Humara assay.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
— 至 120 Years(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Frequency of AML that originate in CD33+ or in which uncontrolled growth is restricted to CD33+ precursors

Extent of clonal hematopoiesis in small numbers of AML cells

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

相似试验

Biomarker Study in Tissue Samples From Patients With... | 临床试验